VYNE Therapeutics Inc.

VYNENasdaq· Pharmaceutical Preparations

Price History

Revenue

$570,000

▲ 13.8% YoY

Net Income

-$26.5M

▲ 33.5% YoY

EPS

$-0.62

▲ 33.3% YoY

Cash

$24.0M

▲ 20.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.